New family of promising, selective silver-based anti-cancer drugs discovered

A family of economical silver-based complexes, simple to synthesize, show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells.

A new family of very promising silver-based anti-cancer drugs has been discovered by researchers in South Africa. The most promising silver thiocyanate phosphine complex among these, called UJ3 for short, has been successfully tested in rats and in human cancer cells in the laboratory. Read more.

ScienceDaily

Gerelateerd,
- Silver bullet to beat cancer? - ScienceDaily

- Antitumor activity of colloidal silver on MCF-7 human breast cancer cells - NCBI
- Silver bullet for cancer: Metal can kill some tumours better than chemotherapy with fewer side effects - Daily Mail